A pilot clinical trial assessing the efficacy and safety of supplementation with a B complex vitamin to reduce the incidence of chemotherapy induced peripheral neuropathy in patients diagnosed with a malignancy.

niversity of Queensland - Centre for Integrative Clinical and Molecular Medicine0 个研究点目标入组 135 人开始时间: 2011年1月21日最近更新: 2020年1月13日

适应症

试验速览

暂无简介。

•1. Newly diagnosed with a neoplastic disease;
•2. Have been prescribed chemotherapy treatment with paclitaxel, vincristine or oxaliplatin.

•1. Participants who will be prescribed any other concurrent investigational products
•2. Currently experiences peripheral neuropathy
•3. Have undergone chemotherapy treatment before with a neurotoxic agent
•4. Have undergone chemotherapy treatment within the last five years
•6. Women who are currently pregnancy or breast feeding
•7. Any patient with established cognitive impairment, alcoholism, intellectual disability or severe mental illness
•8. Any patient found to be deficient in vitamin B12 or folate after initial baseline blood pathology testing.
•9. Any patients taking concurrent multivitamins, nutritional and herbal supplements or fish oils.

发起方

niversity of Queensland - Centre for Integrative Clinical and Molecular Medicine